Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care

About this update from Covalon Technologies Ltd.

Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care .bwalignc { text-align: center; list-style-position: inside } Covalon Technologies Ltd. (TSX: COV; OTCQX: CVALF), an advanced medical technologies company, today announced a series of important milestones reflecting the Company's growing market development and commercial momentum, and deepening engagement across the vascular access, infection prevention, and wound care sectors. Strong Engagement at Infusion Nurses Society Annual Meeting Covalon had a strong presence at the Infusion Nurses Society (INS) Annual Meeting this past weekend, and the Company is pleased to report an exceptionally productive event. The Covalon team engaged in high-quality conversations with clinicians from hospitals, clinics and home infusion organizations, generating meaningful new opportunities and advancing discussions with key decision makers across the healthcare continuum. A highlight of the meeting was a presentation delivered by internationally recognized vascular access expert Dr. Nancy Moureau on the critical topic of contamination of intravenous (IV) connections and access points. Delivered to a highly engaged room, the presentation resonated strongly with clinicians and reinforced what the Covalon team is hearing consistently in the marketplace, that the contamination challenge is a pressing clinical concern, worthy of being addressed with solutions that are proven and purpose-built to protect patients at the point-of-care. "The energy and enthusiasm we experienced at INS this year was tremendous," said Brent Ashton, CEO of Covalon Technologies. "Clinicians across a broad range of care settings are increasingly focused on solving contamination challenges to improve patient safety, and our conversations made it clear that Covalon's solution is highly regarded, relevant and timely. Engagement at the meeting extended beyond the clinical community, with Covalon advancing discussions with a number of industry participants as the Company continues to evaluate opportunities to accelerate its growth strategy and broaden the impact of its technology platforms." Contamination Education Selected for Important Upcoming Conferences Building on the momentum from INS, Covalon is pleased to announce that the topic of IV line connector and access point contamination has al...

View stock analysis, news, and events for Covalon Technologies Ltd.